Provided by Tiger Fintech (Singapore) Pte. Ltd.

NeuroPace Inc.

8.77
-0.2200-2.45%
Volume:79.54K
Turnover:700.47K
Market Cap:290.12M
PE:-10.46
High:8.93
Open:8.93
Low:8.71
Close:8.99
52wk High:18.98
52wk Low:5.45
Shares:33.08M
Float Shares:22.52M
Volume Ratio:0.39
T/O Rate:0.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8387
EPS(LYR):-0.9318
ROE:-176.94%
ROA:-12.39%
PB:14.93
PE(LYR):-9.41

Loading ...

BRIEF-NeuroPace Says Rebecca Kuhn Departs As CFO, To Serve In Advisory Role

Reuters
·
Jun 25

Press Release: NeuroPace Announces Strategic CFO Transition

Dow Jones
·
Jun 25

Cantor Fitzgerald Remains a Buy on NeuroPace (NPCE)

TIPRANKS
·
Jun 16

NeuroPace Inc. Conducted Annual Stockholders' Meeting Virtually

Reuters
·
Jun 13

UBS Reaffirms Their Buy Rating on NeuroPace (NPCE)

TIPRANKS
·
Jun 12

Analysts Offer Insights on Healthcare Companies: MAIA Biotechnology, Inc. (MAIA) and NeuroPace (NPCE)

TIPRANKS
·
Jun 09

BRIEF-Neuropace Inc - Enters Into Credit Agreement With Midcap Funding Iv Trust

Reuters
·
Jun 05

Press Release: NeuroPace Secures Up to $75 Million in Debt Financing

Dow Jones
·
Jun 05

Cantor Fitzgerald Sticks to Their Buy Rating for NeuroPace (NPCE)

TIPRANKS
·
Jun 02

NeuroPace Initiated at Buy by HC Wainwright & Co.

Dow Jones
·
May 28

Buy Rating for NeuroPace: Strong Revenue Growth and Efficacy of RNS System Drive Investment Appeal

TIPRANKS
·
May 28

NeuroPace initiated with a Buy at H.C. Wainwright

TIPRANKS
·
May 28

Optimistic Outlook for NeuroPace: Buy Rating Justified by Subgroup Success and Growth Potential

TIPRANKS
·
May 28

NeuroPace’s Promising Prospects: Buy Rating Affirmed Despite Initial Study Setback

TIPRANKS
·
May 27

Leerink says NeuroPace results disappointing, sees hope on totality of data

TIPRANKS
·
May 27

BUZZ-NeuroPace falls after epilepsy implant fails to meet main study goal

Reuters
·
May 27

NeuroPace Says Epilepsy Trial Meets Safety Goal, Misses Overall Efficacy Target

MT Newswires Live
·
May 27

BRIEF-NeuroPace Announces Preliminary Results from One-Year Data in NAUTILUS Study

Reuters
·
May 27

OrbiMed Advisors LLC Reports Disposal of Common Shares of NeuroPace Inc

Reuters
·
May 17

NeuroPace, Inc. Reports Strong Q1 2025 Earnings

TIPRANKS
·
May 16